Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Clinical

Clinical
Novartis’ Tabrecta (capmatinib) Phase 2 GEOMETRY mono-1 study results for NSCLC published in NEJM

TKI – September 2020 TKI – September 2020 Pivotal GEOMETRY mono-1 study results of capmatinib (Tabrecta) in patients with METex14 metastatic non-small cell lung cancer published in NEJM 02 Sep 2020 Tabrecta (Capmatinib; MET inhibitor) – Incyte/Novartis Data from pivotal […]

by Sandhya Ramalingam

Continue Reading


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id